Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: Antiviral Res. 2017 Dec 14;150:93–100. doi: 10.1016/j.antiviral.2017.12.006

Table 15.

Workshop participants considered that research needed to achieve a cure for chronic hepatitis D was a secondary priority.

Hepatitis D-Specific Antivirals and Immunology
Project Rank
Development of next generation anti-HDV agents based on HDV-specific gene products 1
Role of B and T cell exhaustion in chronicity and pathogenesis 1
How can information about HDV immunovirology be used in the management (treatment and risk assessments) of HDV disease 1